...

Pieris Pharmaceuticals GmbH

Website bezoeken

Over de werkgever

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.

Anticalins are recombinantly engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. Our libraries of more than 100 billion different Anticalins can virtually bind to any target of interest.

Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Roche, Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma.

Pieris, founded in 2001, was funded by premier biotechnology-focused venture capital firms including OrbiMed Advisors as its lead investor as well as Forbion Capital, Gilde Healthcare Partners, Novo Nordisk Ventures, Global Life Science Ventures, BayTech Venture Capital, Bio-M, TCB, KfW and BayernKapital.

Pieris has become a publicly traded company on December 18, 2014 (NASDAQ:PIRS).

Locatie werkgever

Vergelijkbare werkgevers

...
KU Leuven Leuven, België 151 vacatures
...
University of Luxembourg Luxemburg 105 vacatures
...
Ghent University Gent, België 68 vacatures
...
Vrije Universiteit Brussel Brussel, België 63 vacatures
...
ETH Zürich Zürich, Zwitserland 61 vacatures
Meer werkgevers

Dit vind je misschien ook interessant

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) Leestijd: 4 min
...
The genetic detectives discovering who we really are University of Turku Leestijd: 5 min
...
Deciphering the Gut’s Clues to Our Health University of Turku Leestijd: 5 min
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) Leestijd: 5 min
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano Leestijd: 5 min
Meer stories